Hosted on MSN1h
HC Wainwright & Co. Downgrades Inhibikase Therapeutics (IKT)
Fintel reports that on February 12, 2025, HC Wainwright & Co. downgraded their outlook for Inhibikase Therapeutics ...
Sphere 3D (NASDAQ:ANY) Upgraded to Hold at StockNews.com
Sphere 3D (NASDAQ:ANY – Get Free Report) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Tuesday. Separately, HC Wainwright ...
Coinbase Q4 Earnings Preview: Trump Winning 2024 Election 'A Shot In The Arm For The Crypto Industry'
Cryptocurrency company Coinbase Global (NASDAQ:COIN) could highlight record profitability and user metrics when the company ...
AnaptysBio price target raised to $22 from $19 at H.C. Wainwright
H.C. Wainwright analyst Emily Bodnar raised the firm’s price target on AnaptysBio (ANAB) to $22 from $19 and keeps a Neutral rating on the ...
Sage stock price target cut to $12 by H.C. Wainwright
H.C. Wainwright analyst Douglas Tsao revised the price target for Sage Therapeutics (NASDAQ:SAGE) to $12.00 from the previous $14.00 while maintaining a Neutral rating on the company's shares. Tsao's ...
Arvinas price target lowered to $81 from $87 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Arvinas (ARVN) to $81 from $87 and keeps a Buy rating on the shares. Given the company’s ...
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Receives “Outperform” Rating from Royal Bank of Canada
Royal Bank of Canada reissued their outperform rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research report sent to investors on Tuesday,Benzinga reports. They ...